ARTICLE | Distillery Therapeutics
Cancer
November 6, 2018 8:46 PM UTC
In silico, in vitro, cell culture and mouse studies identified a positive allosteric modulator (PAM) of SIRT6 that could help treat hepatocellular carcinoma (HCC). In silico screening of a small molec...
BCIQ Company Profiles
BCIQ Target Profiles